Oracle shares slid 9.5% to $182.20 following its earnings report. While the company posted higher profits driven by cloud revenue, a concurrent dip in software sales and the high cost of building artificial intelligence infrastructure signaled potential pressure on near-term margins. Similarly, Oxford Industries saw its stock drop 8.7% to $39.50 as the company pointed to tariff costs and shifting consumer sentiment as primary drags on its bottom line.
In section Market Quotes
Market Sell-Off Hits Oracle and Oxford Industries After Earnings
Investors punished a wave of companies on Wednesday, sending shares tumbling across sectors as Oracle’s AI-heavy capital expenditure and Oxford Industries’ cautious profit outlook sparked a broad sell-off. The volatility extended to biotech and recycling firms, where planned stock offerings deepened the losses for shareholders after the closing bell.
Capital raising efforts weighed heavily on smaller firms. Humacyte shares fell 12% to $1.18, despite reporting that its bioengineered blood vessel successfully met primary endpoints in a Phase 3 trial, as the company announced an underwritten public stock offering. PureCycle Technologies experienced a sharper decline of 14% to $8.55 after revealing plans for a $145 million stock offering alongside a $250 million sale of convertible senior notes due in 2032.
Comments (0)
No comments yet. Be the first!